{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T09:35:58Z","timestamp":1793871358091,"version":"4.6.1"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.psychres.2025.116552","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T18:36:57Z","timestamp":1747507017000},"page":"116552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Medicinal cannabis in the management of anxiety disorders: A systematic review"],"prefix":"10.1016","volume":"350","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0215-7813","authenticated-orcid":false,"given":"Leah","family":"Roberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3814-1641","authenticated-orcid":false,"given":"Elizabeth","family":"Sorial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1910-5561","authenticated-orcid":false,"given":"Charley A.","family":"Budgeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3022-4868","authenticated-orcid":false,"given":"Kenneth","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Preen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2556-3294","authenticated-orcid":false,"given":"Craig","family":"Cumming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.psychres.2025.116552_bib0001","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/14659891.2021.2006341","article-title":"Expectancies about the effects of cannabidiol products on anxiety symptoms","volume":"28","author":"Altman","year":"2023","journal-title":"J. Subst. Use"},{"issue":"1","key":"10.1016\/j.psychres.2025.116552_bib0002","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s42238-023-00189-6","article-title":"Conflicting forces in the implementation of medicinal cannabis regulation in Uruguay","volume":"5","author":"Alvarez","year":"2023","journal-title":"J. Cannabis. Res."},{"issue":"7","key":"10.1016\/j.psychres.2025.116552_bib0003","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.5665\/sleep.2810","article-title":"A systematic review assessing bidirectionality between sleep disturbances, anxiety, and depression","volume":"36","author":"Alvaro","year":"2013","journal-title":"Sleep."},{"key":"10.1016\/j.psychres.2025.116552_bib0004","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"10.1016\/j.psychres.2025.116552_bib0005","series-title":"Diagnostic and Statistical Manual of Mental disorders: DSM-5\u2122","year":"2013"},{"key":"10.1016\/j.psychres.2025.116552_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctcp.2022.101612","article-title":"Characterizing anxiety, pain, sleep, and quality of life among patients in a state Medical Marijuana Program","volume":"48","author":"Ashare","year":"2022","journal-title":"Complement. Ther. Clin. Pract."},{"key":"10.1016\/j.psychres.2025.116552_bib0007","unstructured":"Australian Bureau of Statistics, 2023. National Study of Mental Health and Wellbeing."},{"issue":"9","key":"10.1016\/j.psychres.2025.116552_bib0008","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1037\/bul0000053","article-title":"Sleep and mental disorders: a meta-analysis of polysomnographic research","volume":"142","author":"Baglioni","year":"2016","journal-title":"Psychol. Bull."},{"issue":"3","key":"10.1016\/j.psychres.2025.116552_bib0009","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/14737175.2023.2181696","article-title":"Comparing the effects of medical cannabis for chronic pain patients with and without co-morbid anxiety: a cohort study","volume":"23","author":"Bapir","year":"2023","journal-title":"Expert. Rev. NeurOther"},{"issue":"6","key":"10.1016\/j.psychres.2025.116552_bib0010","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/head.12570","article-title":"Comprehensive review of medicinal marijuana, cannabinoids, and therapeutic implications in medicine and headache: what a long strange trip it's been\u2026","volume":"55","author":"Baron","year":"2015","journal-title":"Headache: The Journal of Head and Face Pain"},{"issue":"2","key":"10.1016\/j.psychres.2025.116552_bib0011","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/NMD.0b013e3181961d8e","article-title":"Impact of sleep disturbances on PTSD symptoms and perceived health","volume":"197","author":"Belleville","year":"2009","journal-title":"J. Nerv. Ment. Dis."},{"issue":"6","key":"10.1016\/j.psychres.2025.116552_bib0012","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.psychres.2025.116552_bib0013","doi-asserted-by":"crossref","first-page":"586","DOI":"10.31128\/AJGP-04-21-5936","article-title":"Medicinal cannabis for the treatment of anxiety disorders","volume":"51","author":"Berger","year":"2022","journal-title":"Aust. J. Gen. Pract."},{"key":"10.1016\/j.psychres.2025.116552_bib0014","doi-asserted-by":"crossref","unstructured":"Berger, M., Li, E., Rice, S., Davey, C.G., Ratheesh, A., Adams, S., Jackson, H., Hetrick, S., Parker, A., Spelman, T., Kevin, R., McGregor, I.S., McGorry, P., Amminger, G.P., Berger, M., Li, E., Rice, S., Davey, C.G., Ratheesh, A., Adams, S., Jackson, H., Hetrick, S., Parker, A., Spelman, T., Kevin, R., McGregor, I.S., McGorry, P., Amminger, G.P., 2022b. Cannabidiol for Treatment-Resistant Anxiety Disorders in Young People: An Open-Label Trial.","DOI":"10.4088\/JCP.21m14130"},{"issue":"12","key":"10.1016\/j.psychres.2025.116552_bib0015","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S2215-0366(19)30401-8","article-title":"Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis","volume":"6","author":"Black","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"Suppl 2","key":"10.1016\/j.psychres.2025.116552_bib0016","article-title":"A selective review of medical cannabis in cancer pain management","volume":"6","author":"Blake","year":"2018","journal-title":"Ann. Palliat. Med."},{"issue":"5","key":"10.1016\/j.psychres.2025.116552_bib0017","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00213-021-06043-y","article-title":"Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder","volume":"239","author":"Bolsoni","year":"2022","journal-title":"Psychopharmacology. (Berl)"},{"key":"10.1016\/j.psychres.2025.116552_bib0018","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuro.2019.08.002","article-title":"Cannabidiol (CBD) use in psychiatric disorders: a systematic review","volume":"74","author":"Bonaccorso","year":"2019","journal-title":"Neurotoxicology."},{"issue":"2","key":"10.1016\/j.psychres.2025.116552_bib0019","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1089\/can.2020.0056","article-title":"The long-term, prospective, therapeutic impact of cannabis on post-traumatic stress disorder","volume":"7","author":"Bonn-Miller","year":"2022","journal-title":"Cannabis. Cannabinoid. Res."},{"issue":"1","key":"10.1016\/j.psychres.2025.116552_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ajad.12963","article-title":"Cannabis and cannabinoids in mood and anxiety disorders: impact on illness onset and course, and assessment of therapeutic potential","volume":"29","author":"Botsford","year":"2020","journal-title":"Am. J. Addict."},{"issue":"2","key":"10.1016\/j.psychres.2025.116552_bib0021","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/08964289.2019.1683712","article-title":"Perceived efficacy of medical cannabis in the treatment of co-occurring health-related quality of life symptoms","volume":"47","author":"Bruce","year":"2021","journal-title":"Behavioral Medicine"},{"issue":"9","key":"10.1016\/j.psychres.2025.116552_bib0022","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.mp.4001852","article-title":"Treatment-resistant anxiety disorders","volume":"11","author":"Bystritsky","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116552_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.626853","article-title":"Evaluation of Patient Reported Safety and Efficacy of Cannabis From a Survey of Medical Cannabis Patients in Canada","volume":"9","author":"Cahill","year":"2021","journal-title":"Front. Public Health"},{"issue":"5","key":"10.1016\/j.psychres.2025.116552_bib0024","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/JCP.0000000000000180","article-title":"Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation","volume":"34","author":"Cameron","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2025.116552_bib0025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/YCO.0000000000000562","article-title":"Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans","volume":"33","author":"Chadwick","year":"2020","journal-title":"Curr. Opin. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2025.116552_bib0026","first-page":"385","article-title":"Medical cannabis use for patients with post-traumatic stress disorder (PTSD)","volume":"10","author":"Chan","year":"2017","journal-title":"J. Pain. Manage"},{"key":"10.1016\/j.psychres.2025.116552_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2021.101583","article-title":"Sleep and anxiety: From mechanisms to interventions","volume":"61","author":"Chellappa","year":"2022","journal-title":"Sleep. Med. Rev."},{"issue":"1","key":"10.1016\/j.psychres.2025.116552_bib0028","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1016\/j.psychres.2025.116552_bib0029","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s43856-022-00202-8","article-title":"Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial","volume":"2","author":"Dahlgren","year":"2022","journal-title":"Commun. Med. (Lond)"},{"key":"10.1016\/j.psychres.2025.116552_bib0030","unstructured":"Department of Health, 2023. SAS-B Applications."},{"key":"10.1016\/j.psychres.2025.116552_bib0031","article-title":"Anxiety severity and prescription medication utilization in first-time medical marijuana users","volume":"14","author":"Dugosh","year":"2023","journal-title":"J. Affect. Disord. Rep."},{"issue":"4","key":"10.1016\/j.psychres.2025.116552_bib0032","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/17512433.2022.2020640","article-title":"UK Medical Cannabis Registry: an analysis of clinical outcomes of medicinal cannabis therapy for generalized anxiety disorder","volume":"15","author":"Ergisi","year":"2022","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.psychres.2025.116552_bib0033","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/pds.1152","article-title":"Limited use of medicinal cannabis but for labeled indications after legalization","volume":"14","author":"Erkens","year":"2005","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"4","key":"10.1016\/j.psychres.2025.116552_bib0034","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/npr2.12403","article-title":"An observational study of clinical outcome measures in patients treated with cannabis-based medicinal products on the UK Medical Cannabis Registry","volume":"43","author":"Erridge","year":"2023","journal-title":"Neuropsychopharmacol. Rep."},{"issue":"S1","key":"10.1016\/j.psychres.2025.116552_bib0035","doi-asserted-by":"crossref","first-page":"377S","DOI":"10.1002\/j.1552-4604.1981.tb02617.x","article-title":"The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety","volume":"21","author":"Fabre","year":"1981","journal-title":"The Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1016\/j.psychres.2025.116552_bib0036","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000531886","article-title":"Effects of Two Cannabidiol Oil Products on Self-Reported Stress Relief: a Quasi-Experimental Study","volume":"6","author":"Faraj","year":"2023","journal-title":"Med. Cannabis. Cannabinoids."},{"key":"10.1016\/j.psychres.2025.116552_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.965535","article-title":"Online survey of medicinal cannabis users: Qualitative analysis of patient-level data","volume":"13","author":"Garcia-Romeu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.psychres.2025.116552_bib0038","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00213-023-06437-0","article-title":"The effects of cannabidiol on worry and anxiety among high trait worriers: a double-blind, randomized placebo controlled trial","volume":"240","author":"Gournay","year":"2023","journal-title":"Psychopharmacology. (Berl)"},{"issue":"1","key":"10.1016\/j.psychres.2025.116552_bib0039","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/YIC.0000000000000382","article-title":"Tetrahydrocannabinol fails to reduce hair pulling or skin picking: Results of a double-blind, placebo-controlled study of dronabinol","volume":"37","author":"Grant","year":"2022","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2025.116552_bib0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/02791072.2013.873843","article-title":"PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program","volume":"46","author":"Greer","year":"2014","journal-title":"J. Psychoactive Drugs"},{"issue":"10208","key":"10.1016\/j.psychres.2025.116552_bib0041","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/S0140-6736(19)31789-1","article-title":"Public health implications of legalising the production and sale of cannabis for medicinal and recreational use","volume":"394","author":"Hall","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.psychres.2025.116552_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.116049","article-title":"Therapeutic potential of cannabidiol (CBD) in anxiety disorders: a systematic review and meta-analysis","author":"Han","year":"2024","journal-title":"Psychiatry Res."},{"issue":"12","key":"10.1016\/j.psychres.2025.116552_bib0043","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/AJP.0000000000000364","article-title":"The effect of medicinal cannabis on pain and quality-of-life outcomes in chronic pain","volume":"32","author":"Haroutounian","year":"2016","journal-title":"Clin. J. Pain."},{"issue":"2","key":"10.1016\/j.psychres.2025.116552_bib0044","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/brainsci13020325","article-title":"Endocannabinoid system and exogenous cannabinoids in depression and anxiety: a review","volume":"13","author":"Hasbi","year":"2023","journal-title":"Brain Sci."},{"issue":"1","key":"10.1016\/j.psychres.2025.116552_bib0045","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/15504263.2019.1652380","article-title":"The effectiveness of cannabinoids in the treatment of posttraumatic stress disorder (PTSD): a systematic review","volume":"16","author":"Hindocha","year":"2020","journal-title":"J. Dual. Diagn."},{"key":"10.1016\/j.psychres.2025.116552_bib0046","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00406-019-00984-4","article-title":"How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review","volume":"269","author":"Hoch","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.psychres.2025.116552_bib0047","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/0269881117737400","article-title":"The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group","volume":"32","author":"Hundal","year":"2018","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.psychres.2025.116552_bib0048","unstructured":"IHME Global Burden of Disease, 2024. Anxiety disorders prevalence, 2021."},{"key":"10.1016\/j.psychres.2025.116552_bib0049","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.psyneuen.2014.11.002","article-title":"The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: a preliminary randomized, double-blind, placebo-controlled cross-over design study","volume":"51","author":"Jetly","year":"2015","journal-title":"Psychoneuroendocrinology."},{"issue":"6","key":"10.1016\/j.psychres.2025.116552_bib0050","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.clinthera.2023.04.011","article-title":"History of cannabis regulation and medicinal therapeutics: it's complicated","volume":"45","author":"Johnson","year":"2023","journal-title":"Clin. Ther."},{"issue":"2","key":"10.1016\/j.psychres.2025.116552_bib0051","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000517154","article-title":"Much ado about dosing: the needs and challenges of defining a standardized cannabis unit","volume":"4","author":"Jugl","year":"2021","journal-title":"Med. Cannabis. Cannabinoids."},{"key":"10.1016\/j.psychres.2025.116552_bib0052","doi-asserted-by":"crossref","DOI":"10.1002\/acr.20561","article-title":"Measures of anxiety","volume":"63","author":"Julian","year":"2011","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.psychres.2025.116552_bib0053","article-title":"Cognitive-behavioral therapy for anxiety disorders: an update on the empirical evidence","author":"Kaczkurkin","year":"2022","journal-title":"Dialogues. Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.psychres.2025.116552_bib0054","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijpsycho.2013.05.010","article-title":"Sleep and emotions: Bidirectional links and underlying mechanisms: Psychophysiology and Cognitive Neuroscience of Sleep and Sleep Disorders","volume":"89","author":"Kahn","year":"2013","journal-title":"International journal of psychophysiology"},{"issue":"6","key":"10.1016\/j.psychres.2025.116552_bib0055","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1089\/can.2020.0120","article-title":"Cannabinoid profiles in medical cannabis users: effects of age, gender, symptoms, and duration of use","volume":"7","author":"Kalaba","year":"2022","journal-title":"Cannabis. Cannabinoid. Res."},{"issue":"8","key":"10.1016\/j.psychres.2025.116552_bib0056","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/da.23032","article-title":"Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: a human laboratory study","volume":"37","author":"Kayser","year":"2020","journal-title":"Depress. Anxiety."},{"issue":"3","key":"10.1016\/j.psychres.2025.116552_bib0057","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/mpr.1359","article-title":"Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States","volume":"21","author":"Kessler","year":"2012","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"10.1016\/j.psychres.2025.116552_bib0058","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42238-019-0012-y","article-title":"The therapeutic role of Cannabidiol in mental health: a systematic review","volume":"2","author":"Khan","year":"2020","journal-title":"J. Cannabis. Res."},{"key":"10.1016\/j.psychres.2025.116552_bib0059","doi-asserted-by":"crossref","DOI":"10.1177\/21501319221129734","article-title":"An observational cross-sectional survey exploring the indications for and responses to medical marijuana use in certified patients in Pennsylvania","volume":"13","author":"Kimless","year":"2022","journal-title":"J. Prim. Care Community Health"},{"key":"10.1016\/j.psychres.2025.116552_bib0060","series-title":"Standard Quality Assessment Criteria For Evaluating Primary Research Papers from a Variety of Fields","author":"Kmet","year":"2004"},{"key":"10.1016\/j.psychres.2025.116552_bib0061","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.euroneuro.2020.04.009","article-title":"Experiences with medical cannabis in the treatment of veterans with PTSD: Results from a focus group discussion","volume":"36","author":"Krediet","year":"2020","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2025.116552_bib0062","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.euroneuro.2022.04.003","article-title":"Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: a randomised controlled trial","volume":"59","author":"Kwee","year":"2022","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2025.116552_bib0063","doi-asserted-by":"crossref","unstructured":"Kwee, C.M.B., van der Flier, F.E., Duits, P., van Balkom, A., Cath, D.C., Baas, J.M.P., Kwee, C.M.B., van der Flier, F.E., Duits, P., van Balkom, A.J.L.M., Cath, D.C., Baas, J.M.P., 2023. Effects of cannabidiol on fear conditioning in anxiety disorders: decreased threat expectation during retention, but no enhanced fear re-extinction.","DOI":"10.1016\/j.nsa.2023.103433"},{"key":"10.1016\/j.psychres.2025.116552_bib0064","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jad.2020.05.132","article-title":"Short and long-term effects of cannabis on symptoms of post-traumatic stress disorder","volume":"274","author":"LaFrance","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.psychres.2025.116552_bib0065","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/07067437211043393","article-title":"Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients-Ontario and Alberta, Canada","volume":"67","author":"Lee","year":"2022","journal-title":"Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie"},{"issue":"5","key":"10.1016\/j.psychres.2025.116552_bib0066","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5694\/mja17.01247","article-title":"Medicinal cannabis in Australia, 2016: the cannabis as medicine survey (CAMS-16)","volume":"209","author":"Lintzeris","year":"2018","journal-title":"Medical Journal of Australia"},{"key":"10.1016\/j.psychres.2025.116552_bib0067","series-title":"Manual For the Depression Anxiety Stress Scales","author":"Lovibond","year":"1995"},{"key":"10.1016\/j.psychres.2025.116552_bib0068","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","article-title":"Practical considerations in medical cannabis administration and dosing","volume":"49","author":"MacCallum","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.psychres.2025.116552_bib0069","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.729800","article-title":"Antidepressant and anxiolytic effects of medicinal cannabis use in an observational trial","volume":"12","author":"Martin","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116552_bib0070","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2019.02466","article-title":"Anxiolytic Effects of Repeated Cannabidiol Treatment in Teenagers With Social Anxiety Disorders","volume":"10","author":"Masataka","year":"2019","journal-title":"Front. Psychol."},{"issue":"2","key":"10.1016\/j.psychres.2025.116552_bib0071","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3138\/jmvfh-2019-0028","article-title":"Use of a synthetic cannabinoid (nabilone) in the ongoing management of posttraumatic stress disorder nightmares in the Canadian Armed Forces: Results of an anonymous online survey","volume":"6","author":"Meakin","year":"2020","journal-title":"J. Mil. Veteran. Fam. Health"},{"issue":"5","key":"10.1016\/j.psychres.2025.116552_bib0072","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1176\/appi.ajp.157.5.669","article-title":"Quality of life in individuals with anxiety disorders","volume":"157","author":"Mendlowicz","year":"2000","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2025.116552_bib0073","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.mppsy.2007.01.007","article-title":"Epidemiology of anxiety disorders","volume":"6","author":"Michael","year":"2007","journal-title":"Psychiatry"},{"key":"10.1016\/j.psychres.2025.116552_bib0074","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42238-021-00061-5","article-title":"Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems","volume":"3","author":"Moltke","year":"2021","journal-title":"J. Cannabis. Res."},{"key":"10.1016\/j.psychres.2025.116552_bib0075","doi-asserted-by":"crossref","unstructured":"Moreno-Sanz, G., Madiedo, A., Lynskey, M., Brown, M.R.D., Moreno-Sanz, G., Madiedo, A., Lynskey, M., Brown, M.R.D., 2022. \"Flower Power\": Controlled Inhalation of THC-Predominant Cannabis Flos Improves Health-Related Quality of Life and Symptoms of Chronic Pain and Anxiety in Eligible UK Patients.","DOI":"10.3390\/biomedicines10102576"},{"key":"10.1016\/j.psychres.2025.116552_bib0076","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.1014630","article-title":"Medical cannabis for treatment-resistant combat PTSD","volume":"13","author":"Nacasch","year":"2023","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116552_bib0077","series-title":"The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research","year":"2017"},{"key":"10.1016\/j.psychres.2025.116552_bib0078","first-page":"1","article-title":"Experiences and needs of children and adolescents affected by a parent\u2019s acquired brain injury: a systematic review and thematic synthesis","author":"Ohan","year":"2023","journal-title":"Disabil. Rehabil."},{"issue":"5","key":"10.1016\/j.psychres.2025.116552_bib0079","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.cpr.2007.01.015","article-title":"Quality of life in the anxiety disorders: a meta-analytic review","volume":"27","author":"Olatunji","year":"2007","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.psychres.2025.116552_bib0080","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.psychres.2025.116552_bib0081","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1017\/S1121189X00004590","article-title":"The diffusion and the reason for the use of complementary and alternative medicine among users of mental health services: a systematic review of literature","volume":"16","author":"Pellegrini","year":"2007","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.psychres.2025.116552_bib0082","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-019-1243-x","article-title":"Benefits and harms of medical cannabis: a scoping review of systematic reviews","volume":"8","author":"Pratt","year":"2019","journal-title":"Syst. Rev."},{"issue":"1","key":"10.1016\/j.psychres.2025.116552_bib0083","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s42238-021-00078-w","article-title":"Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic","volume":"3","author":"Rapin","year":"2021","journal-title":"J. Cannabis. Res."},{"issue":"8","key":"10.1016\/j.psychres.2025.116552_bib0084","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00213-023-06399-3","article-title":"Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry","volume":"240","author":"Rifkin-Zybutz","year":"2023","journal-title":"Psychopharmacology. (Berl)"},{"issue":"8","key":"10.1016\/j.psychres.2025.116552_bib0085","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40261-014-0212-3","article-title":"Preliminary, open-label, pilot study of add-on oral DELTA9-tetrahydrocannabinol in chronic post-traumatic stress disorder","volume":"34","author":"Roitman","year":"2014","journal-title":"Clin. Drug Investig."},{"issue":"1","key":"10.1016\/j.psychres.2025.116552_bib0086","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000512342","article-title":"Demographics, perceptions, and use of medical marijuana among patients in Florida","volume":"4","author":"Rosenthal","year":"2021","journal-title":"Med. Cannabis. Cannabinoids."},{"key":"10.1016\/j.psychres.2025.116552_bib0087","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114573","article-title":"Medical cannabis use in Canada and its impact on anxiety and depression: a retrospective study","volume":"313","author":"Sachedina","year":"2022","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.psychres.2025.116552_bib0088","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1017\/S1355617721000114","article-title":"An Observational, Longitudinal Study of Cognition in Medical Cannabis Patients over the Course of 12 Months of Treatment: Preliminary Results","volume":"27","author":"Sagar","year":"2021","journal-title":"Journal of the International Neuropsychological Society"},{"issue":"5","key":"10.1016\/j.psychres.2025.116552_bib0089","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00213-021-05855-2","article-title":"Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty21","volume":"239","author":"Sakal","year":"2022","journal-title":"Psychopharmacology. (Berl)"},{"issue":"1","key":"10.1016\/j.psychres.2025.116552_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-019-2409-8","article-title":"Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review","volume":"20","author":"Sarris","year":"2020","journal-title":"BMC. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2025.116552_bib0091","first-page":"397","article-title":"Medical cannabis use in military and police veterans diagnosed with post-traumatic stress disorder (PTSD)","volume":"10","author":"Smith","year":"2017","journal-title":"J. Pain. Manage"},{"key":"10.1016\/j.psychres.2025.116552_bib0092","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.856846","article-title":"Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic","volume":"13","author":"Souza","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3 & 4","key":"10.1016\/j.psychres.2025.116552_bib0093","article-title":"The state-trait anxiety inventory","volume":"5","author":"Spielberger","year":"1971","journal-title":"Revista Interamericana de Psicologia\/Interamerican journal of psychology"},{"issue":"10","key":"10.1016\/j.psychres.2025.116552_bib0094","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.psychres.2025.116552_bib0095","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/87551225231180796","article-title":"The effectiveness and adverse events of cannabidiol and tetrahydrocannabinol used in the treatment of anxiety disorders in a PTSD subpopulation: An interim analysis of an observational study","volume":"39","author":"Stack","year":"2023","journal-title":"Journal of Pharmacy Technology"},{"issue":"6","key":"10.1016\/j.psychres.2025.116552_bib0096","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1089\/can.2022.0062","article-title":"A Double-Blind, Randomized, Placebo-Controlled Test of the Effects of Cannabidiol on Experiences of Test Anxiety Among College Students","volume":"8","author":"Stanley","year":"2023","journal-title":"Cannabis. Cannabinoid. Res."},{"key":"10.1016\/j.psychres.2025.116552_bib0097","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2022.12.022","article-title":"THC and CBD: Similarities and differences between siblings","author":"Stella","year":"2023","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.psychres.2025.116552_bib0098","first-page":"106","article-title":"A unified framework for bias assessment in clinical research","volume":"17","author":"Stone","year":"2019","journal-title":"JBI. Evid. Implement."},{"issue":"4","key":"10.1016\/j.psychres.2025.116552_bib0099","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1192\/bjp.183.4.299","article-title":"Functional health status, chronic medical conditions and disorders of mood","volume":"183","author":"Surtees","year":"2003","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2025.116552_bib0100","article-title":"Medicinal use of different cannabis strains: results from a large prospective survey in Germany","author":"Szejko","year":"2024","journal-title":"PharmacoPsychiatry"},{"key":"10.1016\/j.psychres.2025.116552_bib0101","doi-asserted-by":"crossref","DOI":"10.1016\/j.janxdis.2022.102632","article-title":"Posttraumatic stress disorder, sleep and medical cannabis treatment: a daily diary study","volume":"92","author":"Sznitman","year":"2022","journal-title":"J. Anxiety. Disord."},{"issue":"9","key":"10.1016\/j.psychres.2025.116552_bib0102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0290549","article-title":"Health-related quality of life in patients accessing medicinal cannabis in Australia: The QUEST initiative results of a 3-month follow-up observational study","volume":"18","author":"Tait","year":"2023","journal-title":"PLoS. One"},{"issue":"5","key":"10.1016\/j.psychres.2025.116552_bib0103","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.janxdis.2012.02.010","article-title":"Non-adherence and non-response in the treatment of anxiety disorders","volume":"26","author":"Taylor","year":"2012","journal-title":"J. Anxiety. Disord."},{"key":"10.1016\/j.psychres.2025.116552_bib0104","unstructured":"Therapeutic Goods Administration, 2022. Medicinal cannabis products by active ingredients."},{"key":"10.1016\/j.psychres.2025.116552_bib0105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpsychires.2019.01.024","article-title":"Cannabis use behaviors and prevalence of anxiety and depressive symptoms in a cohort of Canadian medicinal cannabis users","volume":"111","author":"Turna","year":"2019","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.psychres.2025.116552_bib0106","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000534710","article-title":"Improved post-traumatic stress disorder symptoms and related sleep disturbances after initiation of medical marijuana use: evidence from a prospective single arm pilot study","volume":"6","author":"Vaddiparti","year":"2023","journal-title":"Med. Cannabis. Cannabinoids."},{"issue":"4","key":"10.1016\/j.psychres.2025.116552_bib0107","first-page":"40","article-title":"Faking it: social desirability response bias in self-report research","volume":"25","author":"Van de Mortel","year":"2008","journal-title":"Australian Journal of Advanced Nursing, The"},{"issue":"11","key":"10.1016\/j.psychres.2025.116552_bib0108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272241","article-title":"A large Australian longitudinal cohort registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two years","volume":"17","author":"Vickery","year":"2022","journal-title":"PLoS. One"},{"issue":"10258","key":"10.1016\/j.psychres.2025.116552_bib0109","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.psychres.2025.116552_bib0110","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","article-title":"Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients","volume":"10","author":"Wade","year":"2004","journal-title":"Multiple Sclerosis Journal"},{"issue":"1","key":"10.1016\/j.psychres.2025.116552_bib0111","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/s13063-023-07543-2","article-title":"A small clinical trial of vaporized cannabis for PTSD: suggestive results and directions for future study","volume":"24","author":"Walsh","year":"2023","journal-title":"Trials"},{"issue":"13","key":"10.1016\/j.psychres.2025.116552_bib0112","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1503\/cmaj.071178","article-title":"Adverse effects of medical cannabinoids: a systematic review","volume":"178","author":"Wang","year":"2008","journal-title":"CMAJ."},{"issue":"3","key":"10.1016\/j.psychres.2025.116552_bib0113","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1037\/pas0000486","article-title":"The Clinician-Administered PTSD Scale for DSM\u20135 (CAPS-5): Development and initial psychometric evaluation in military veterans","volume":"30","author":"Weathers","year":"2018","journal-title":"Psychol. Assess."},{"issue":"8","key":"10.1016\/j.psychres.2025.116552_bib0114","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1037\/pas0001244","article-title":"The Cannabis Effects Expectancy Questionnaire\u2013Medical (CEEQ-M): Preliminary psychometric properties and longitudinal validation within a clinical trial","volume":"35","author":"Weiss","year":"2023","journal-title":"Psychol. Assess."},{"key":"10.1016\/j.psychres.2025.116552_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.nlm.2023.107758","article-title":"Cannabinoid modulation of corticolimbic activation during extinction learning and fear renewal in adults with posttraumatic stress disorder","volume":"201","author":"Zabik","year":"2023","journal-title":"Neurobiology of Learning & Memory"},{"issue":"4","key":"10.1016\/j.psychres.2025.116552_bib0116","article-title":"The use of medical cannabis in common medical conditions excluding cancer","volume":"10","author":"Zaki","year":"2017","journal-title":"J. Pain. Manage"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125002008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125002008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:55:21Z","timestamp":1778565321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178125002008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":116,"alternative-id":["S0165178125002008"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116552","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medicinal cannabis in the management of anxiety disorders: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116552","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116552"}}